02.05.2013 | M M Al-Ansari, S F Hendrayani, A I Shehata, A Aboussekhra, Oncogene, 2013

p16INK4A Represses the paracrine tumor-promoting effects of breast stromal fibroblasts Oncogene 32, 2372 (02 May 2013). doi:10.1038/onc.2013.58 Authors: M M Al-Ansari, S F Hendrayani, A I Shehata & A Aboussekhra

mehr

25.04.2013 | K Asada; T Ando; T Niwa; S Nanjo; N Watanabe; E Okochi-Takada; T Yoshida; K Miyamoto; S Enomoto; M Ichinose; T Tsuka ..., Oncogene, 2013

FHL1 on chromosome X is a single-hit gastrointestinal tumor-suppressor gene and contributes to the formation of an epigenetic field defect Oncogene 32, 2140 (25 April 2013). doi:10.1038/onc.2012.228 Authors: K Asada, T Ando, T Niwa, S Nanjo, N Watanabe, E ...

mehr

28.02.2013 | D Yin; S Ogawa; N Kawamata; A Leiter; M Ham; D Li; N B Doan; J W Said; K L Black; H Phillip Koeffler, Oncogene, 2013

miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme Oncogene 32, 1155 (28 February 2013). doi:10.1038/onc.2012.132 Authors: D Yin, S Ogawa, N Kawamata, A Leiter, M Ham, D Li, N B Doan, J W Said, K L Black & H Phillip ...

mehr

28.02.2013 | R F Hennigan; C A Moon; L M Parysek; K R Monk; G Morfini; S Berth; S Brady; N Ratner, Oncogene, 2013

The NF2 tumor suppressor regulates microtubule-based vesicle trafficking via a novel Rac, MLK and p38SAPK pathway Oncogene 32, 1135 (28 February 2013). doi:10.1038/onc.2012.135 Authors: R F Hennigan, C A Moon, L M Parysek, K R Monk, G Morfini, S Berth, S ...

mehr

14.02.2013 | C Cavallari; V Fonsato; M B Herrera; S Bruno; C Tetta; G Camussi, Oncogene, 2013

Role of Lefty in the anti tumor activity of human adult liver stem cells Oncogene 32, 819 (14 February 2013). doi:10.1038/onc.2012.114 Authors: C Cavallari, V Fonsato, M B Herrera, S Bruno, C Tetta & G Camussi

mehr

31.01.2013 | S Origanti; S-r Cai; A Z Munir; L S White; H Piwnica-Worms, Oncogene, 2013

Synthetic lethality of Chk1 inhibition combined with p53 and/or p21 loss during a DNA damage response in normal and tumor cells Oncogene 32, 577 (31 January 2013). doi:10.1038/onc.2012.84 Authors: S Origanti, S-r Cai, A Z Munir, L S White & H ...

mehr

31.01.2013 | H Yang; Y Liu; F Bai; J-Y Zhang; S-H Ma; J Liu; Z-D Xu; H-G Zhu; Z-Q Ling; D Ye; K-L Guan; Y Xiong, Oncogene, 2013

Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation Oncogene 32, 663 (31 January 2013). doi:10.1038/onc.2012.67 Authors: H Yang, Y Liu, F Bai, J-Y Zhang, S-H Ma, J Liu, Z-D Xu, H-G Zhu, Z-Q Ling, D Ye, K-L ...

mehr

31.01.2013 | F Baumgartner; C Woess; V Pedit; A Tzankov; V Labi; A Villunger, Oncogene, 2013

Minor cell-death defects but reduced tumor latency in mice lacking the BH3-only proteins Bad and Bmf Oncogene 32, 621 (31 January 2013). doi:10.1038/onc.2012.78 Authors: F Baumgartner, C Woess, V Pedit, A Tzankov, V Labi & A Villunger

mehr

31.01.2013 | S Ley; A Weigert; B Weichand; N Henke; B Mille-Baker; R A J Janssen; B Brüne, Oncogene, 2013

The role of TRKA signaling in IL-10 production by apoptotic tumor cell-activated macrophages Oncogene 32, 631 (31 January 2013). doi:10.1038/onc.2012.77 Authors: S Ley, A Weigert, B Weichand, N Henke, B Mille-Baker, R A J Janssen & B Brüne

mehr

24.01.2013 | X Li; P D Stevens; H Yang; P Gulhati; W Wang; B M Evers; T Gao, Oncogene, 2013

The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer Oncogene 32, 471 (24 January 2013). doi:10.1038/onc.2012.66 Authors: X Li, P D Stevens, H Yang, P Gulhati, W Wang, B M ...

mehr